Latent TGF‐β1 activation by platelets
Authors:
- 29 October 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 199 (1) , 67-76
Abstract
Platelets are a major source of transforming growth factor‐β1 (TGF‐β1) in the circulation as they release latent growth factor in response to activation. We report here that human platelets, when stimulated with thrombin, activated a significant proportion of the latent TGF‐β released. Latent TGF‐β activation was independent of cytokine release, since activation was delayed compared to platelet degranulation. Activation occured in releasates and did not require the continuous presence of platelets. Classical mechanisms of latent TGF‐β activation were not involved, since activation was not affected by gene deletion and/or inhibitors of the known TGF‐β activators/co‐factors, thrombospondin‐1 (TSP‐1), mannose 6‐phosphate/insulin‐like growth factor‐II receptor (M6P/IGF‐IIR), plasminogen/plasmin, or several other candidate proteases. In contrast, latent TGF‐β activation was significantly inhibited by the furin inhibitors, decanoyl‐Arg‐Val‐Lys‐Arg‐chloromethyl ketone and L‐hexaarginine. We show that platelets contain a furin‐like enzyme which is released upon platelet activation. We conclude that, following activation, platelets release and activate latent TGF‐β1 via mechanisms involving the release and activity of a furin‐like proprotein convertase. This novel mechanism of latent TGF‐β activation might represent an important mediator and therapeutic target of platelet TGF‐β1 functions, for example, in early wound repair, fibrosis, or arteriosclerosis. J. Cell. Physiol. 199: 67–76, 2004Keywords
This publication has 40 references indexed in Scilit:
- Thrombospondin 1 does not activate transforming growth factor β1 in a chemically defined system or in smooth-muscle-cell culturesBiochemical Journal, 2000
- Activation of Platelet-transforming Growth Factor β-1 in the Absence of Thrombospondin-1Journal of Biological Chemistry, 2000
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-βJournal of Biological Chemistry, 1999
- Thrombospondin-1 Is a Major Activator of TGF-β1 In VivoCell, 1998
- Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.Journal of Clinical Investigation, 1998
- Transforming growth factor‐β: activity and efficacy in animal models of wound healingWound Repair and Regeneration, 1995
- Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma cell invasiveness in vitroExperimental Cell Research, 1992
- Platelets, platelet-derived growth factor and arteriosclerosisCellular and Molecular Life Sciences, 1988
- Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-βScience, 1987